HHTM

EDEN PRAIRIE, MINNESOTA – Starkey has announced that the company has been awarded the prestigious 2024 National Access Award by the Hearing Loss Association of America (HLAA) last month. The award was presented at the recent HLAA Convention in Phoenix, Arizona and accepted by Dave Fabry, Ph.D., Starkey’s Chief Hearing Health Officer. The HLAA National Access Award was presented to Starkey in

Three years ago, in July 2021, This Week in Hearing was launched with a vision to explore and highlight the advancements in the hearing industry. This month we celebrate our third anniversary as a leading platform for hearing-related content, having conducted over 220 interviews with a diverse array of voices. Our episodes have delved into a wide range of topics,

Host Bob Traynor sits down with Kerrie Coughlin, Vice President of Marketing & Innovation at Rexton, to discuss the company’s new Reach technology platform. The conversation highlights the capabilities of the Reach platform, with the first model to utilize this new platform being the Rexton Reach R-Li T, a rechargeable receiver-in-canal (RIC) hearing aid. Coughlin explains that Reach incorporates advanced

The conference program for the 68th International Congress of Hearing Aid Acousticians is now available, featuring exciting lectures from outstanding speakers. This year, the focus is on Denmark, the partner country, highlighting their contributions to the field. Participants in the 68th EUHA Congress, set for October 16-18, 2024, in Hanover, can expect a comprehensive program featuring the latest in hearing

July 25, 2024 – London – HearAngel (a LimitEar company) and Sonical, Inc. announced a software licensing agreement to integrate the HearAngel smart hearing safeguarding solution into Sonical’s CosmOS operating system for headphones. This collaboration allows manufacturers using the Sonical platform to offer hearing safeguarding as either a standard feature or user option. “CosmOS is enabling the next generation of

JVC has reported significant success with its innovative hearing rehabilitation approach over the past six months. This advancement leverages Tuned’s technology, resulting in impressive user satisfaction and performance. Leveraging Tuned’s AI Platform Notably, the return rate of JVC’s OTC hearing aids is 13%, significantly lower than the industry average. This success is credited to Tuned’s AI Audiology Platform, which offers

Researchers have uncovered significant findings linking microplastic exposure to hearing loss and balance issues in mice. The study, published in the Journal of Hazardous Materials, delves into the potential health risks posed by microplastics, particularly polyethylene (PE), a common plastic found in various consumer products. The study, led by Javeria Zaheer and colleagues, investigated the effects of microplastic polyethylene on

Washington, D.C.— The American Cochlear Implant Alliance (ACI Alliance) recently elected new board members and thanked outgoing members during CI2024 Vancouver: 17th International Conference on Cochlear Implants and Other Implantable Technologies held earlier this month in Vancouver, Canada. The newly elected board members are: Kenneth H. Lee, MD, PhD UT Southwestern Medical Center Professor, Department of Otolaryngology-Head & Neck Surgery

Evan Solot is a celebrated music composer and trumpet player whose illustrious career spans over five decades, featuring collaborations with legends like Frank Sinatra and Bette Midler. In this episode, host Shari Eberts delves into Solot’s remarkable journey, focusing on how he has navigated the challenges of hearing loss without letting it hinder his professional success. Solot discusses the adaptations

MONTPELLIER, FRANCE – Sensorion (FR0012596468 – ALSEN), a leading clinical-stage biotechnology company specializing in therapies for hearing loss disorders, has announced a positive recommendation from the independent Data Safety Monitoring Board (DSMB) for the continuation of its NOTOXIS Phase 2a Proof-of-Concept (POC) clinical trial. This trial investigates the efficacy and safety of SENS-401 in preventing Cisplatin-Induced Ototoxicity (CIO). The DSMB